NFKB1 and rheumatoid arthritis: Its role in RA has been extensively reviewed and is mainly related to the mechanism of action of methotrexate, phosphoinositide 3-kinases (PI3Ks)/protein kinase B (PKB), and NF-kB signaling pathways.